Statements (91)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Planned_Parenthood
|
| gptkbp:application |
applied to the skin
transdermal |
| gptkbp:approves |
gptkb:2001
gptkb:FDA |
| gptkbp:availability |
varies by country
|
| gptkbp:available_on |
generic version
|
| gptkbp:brand |
gptkb:Ortho_Evra
|
| gptkbp:campaigns |
promote awareness
|
| gptkbp:clinical_trial |
conducted prior to approval
studied for efficacy studied for safety studied for side effects |
| gptkbp:contraindication |
liver disease
certain cancers history of blood clots smoking over age 35 |
| gptkbp:counseling_services |
importance of adherence
important for new users discuss risks and benefits monitor for side effects follow-up appointments recommended discuss alternative methods |
| gptkbp:cultural_acceptance |
widely accepted in many regions
|
| gptkbp:demographics |
women of reproductive age
|
| gptkbp:discontinuation_reasons |
side effects
personal preference cost concerns |
| gptkbp:dosage_form |
gptkb:patches
|
| gptkbp:duration |
3 weeks
|
| gptkbp:educational_resources |
provided to patients
|
| gptkbp:filter_type |
weekly
|
| gptkbp:financial_support |
available
|
| gptkbp:formulation |
gptkb:patches
combination hormonal |
| https://www.w3.org/2000/01/rdf-schema#label |
Ortho Evra
|
| gptkbp:ingredients |
gptkb:norelgestromin
gptkb:ethinyl_estradiol |
| gptkbp:interacts_with |
antibiotics
anticonvulsants HIV medications |
| gptkbp:is_effective_against |
over 99% with perfect use
91% with typical use |
| gptkbp:is_monitored_by |
blood pressure checks
|
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:marketed_as |
gptkb:Evra
gptkb:Australia gptkb:Canada gptkb:United_Kingdom gptkb:United_States |
| gptkbp:marketing_strategy |
direct-to-consumer advertising
|
| gptkbp:packaging |
sealed pouch
monthly supply |
| gptkbp:patch-free_interval |
1 week
|
| gptkbp:patient_population |
consult healthcare provider
|
| gptkbp:patient_reviews |
available online
|
| gptkbp:previous_name |
gptkb:norelgestromin/ethinyl_estradiol
|
| gptkbp:price |
varies by insurance
|
| gptkbp:project |
new formulations being researched
|
| gptkbp:provides_guidance_on |
recommended for certain patients
|
| gptkbp:public_perception |
mixed reviews
|
| gptkbp:regulatory_compliance |
prescription only
impact availability |
| gptkbp:related_to |
reproductive health
family planning contraceptive methods women's health hormonal contraception combination birth control |
| gptkbp:release_year |
gptkb:2001
|
| gptkbp:replaced_by |
gptkb:Xulane
|
| gptkbp:research |
ongoing for long-term effects
|
| gptkbp:service_frequency |
weekly
|
| gptkbp:shelf_life |
1 year
|
| gptkbp:side_effect |
headache
nausea skin irritation thromboembolic events weight gain breast tenderness |
| gptkbp:social_media_presence |
active on platforms
|
| gptkbp:storage |
room temperature
|
| gptkbp:symptoms |
return of fertility
menstrual cycle changes possible pregnancy symptoms |
| gptkbp:type_of_care |
important for effectiveness
|
| gptkbp:type_of_insurance |
often covered
|
| gptkbp:used_for |
contraception
|
| gptkbp:withdrawal_method |
remove for 7 days
|
| gptkbp:bfsParent |
gptkb:Ortho_Tri-Cyclen
|
| gptkbp:bfsLayer |
5
|